Literature DB >> 23512377

Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature.

M Sebastiani1, C U Manzini, F Campomori, A Spinella, C Vacchi, D Giuggioli, D Giuggoli, F Schepis, C Ferri.   

Abstract

Relapsing polychondritis is a rare immune-mediated condition, characterized by episodic inflammation of the cartilaginous tissue, in particular the ears, nose, and eyes, and involvement of joints and respiratory tract. Nearly one third of patients showed other associated diseases, such as systemic vasculitides, connective tissue diseases, or myelodysplastic syndromes. Antiphospholipid antibodies can be found in relapsing polychondritis in patients with no clinical thrombotic disease. However, when antiphospholipid syndrome is present, its clinical manifestations can be severe and life threatening. We describe the case of a patient with relapsing polychondritis associated to Budd-Chiari syndrome due to antiphospholipid syndrome. The present clinical observations together with the updated review of the literature suggest a search for antiphospholipid antibodies in all patients with relapsing polychondritis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512377     DOI: 10.1007/s10067-013-2229-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

Review 1.  Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.

Authors:  G Espinosa; J Font; J C García-Pagan; D Tàssies; J C Reverter; C Gaig; F Cervantes; R Cervera; J Bosch; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-11       Impact factor: 1.889

Review 2.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

3.  Antiphospholipid syndrome and relapsing polychondritis: an unusual association.

Authors:  S Sciascia; M Bazzan; S Baldovino; A Vaccarino; D Rossi; A Russo; D Roccatello
Journal:  Lupus       Date:  2011-07-22       Impact factor: 2.911

4.  Lupus anticoagulant and thrombosis in relapsing polychondritis.

Authors:  I Quéré; C Biron; A Dubois
Journal:  J Rheumatol       Date:  1996-05       Impact factor: 4.666

5.  Relapsing polychondritis presenting with recurrent venous thrombosis in association with anticardiolipin antibody.

Authors:  M Empson; S Adelstein; R Garsia; W Britton
Journal:  Lupus       Date:  1998       Impact factor: 2.911

6.  [Antiphospholipid syndrome and atrophic polychondritis].

Authors:  J C Piette; T Papo; Z Amoura; O Blétry; L Marie; V Saada; C Francès; P Godeau
Journal:  Rev Med Interne       Date:  1997       Impact factor: 0.728

Review 7.  Immunosuppression, liver injury and post-transplant HCV recurrence.

Authors:  S Ciesek; H Wedemeyer
Journal:  J Viral Hepat       Date:  2011-11-07       Impact factor: 3.728

Review 8.  [Antiphospholipid syndrome diagnosis: an update].

Authors:  Benoit Visseaux; Julien Masliah-Planchon; Anne-Marie Fischer; Luc Darnige
Journal:  Ann Biol Clin (Paris)       Date:  2011 Jul-Aug       Impact factor: 0.459

Review 9.  Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome.

Authors:  S Pelletier; B Landi; J C Piette; P Ekert; A Coutellier; C Desmoulins; J P Fadlallah; S Herson; D Valla
Journal:  J Hepatol       Date:  1994-07       Impact factor: 25.083

10.  [Systemic lupus erythematosus and/or relapsing polychondritis with catastrophic antiphospholipid syndrome].

Authors:  M Roux; M Fabre; J Ninet
Journal:  Rev Med Interne       Date:  2004-01       Impact factor: 0.728

View more
  2 in total

Review 1.  Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

Authors:  Antonio Vitale; Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Francesco Molinaro; Mario Messina; Florenzo Iannone; Luca Cantarini
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 2.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.